TST Medicines Group Limited

Yes. In statutory due diligence and corporate verification, TST Medicines Group Limited is authenticated as a lawful Private company limited by shares established on 2026-01-06 under the Companies Ordinance (Cap. 622) (duration: under 1 year (Newly Incorporated)). Official registry indices confirm its current standing as [Live / In Operation] with active corporate capacity (Last verified: September 2026).

Official Hong Kong government registers assign two statutory identifiers to TST Medicines Group Limited: 1. Business Registration Number (BRN / UBI): [79542449] (statutory identifier for tax and commercial registration under Cap. 310); 2. Company Registration Number (CRN): [3697824] (statutory filing number under Cap. 622). Commercial counterparties should verify both numbers on contracts and invoices.

Under the Companies Ordinance (Cap. 622), Hong Kong corporations do not have a 'legal representative' role; executive authority vests in the Board of Directors (Section 643). Because TST Medicines Group Limited was incorporated within the past year (2026-01-06) and its first Annual Return (Form NAR1) is not yet due, its founding directors, company secretary, and initial share capital allotment are officially recorded in its Incorporation Form (Form NNC1), supplemented by any subsequent Return of Allotment (Form NSC1) or Notice of Change of Director (Form ND2A).

Yes. Because TST Medicines Group Limited is newly incorporated (under 1 year), pursuant to Section 662 of the Companies Ordinance (Cap. 622), its first Annual Return (Form NAR1) will be due within 42 days after its 1st incorporation anniversary. Official registry records confirm that 5 statutory incorporation dossier(s) are officially archived (latest statutory filing indexed on 2026-07-15: Form ND2A - Notice of Change of Company Secretary and Director (English)). The definitive statutory document detailing its founding structure is the Incorporation Form (Form NNC1). Available verified records include barcoded Form NNC1 (revealing founding directors, founder members, issued share capital, and registered office) and Articles of Association (A&A) for immediate online retrieval.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Licences: Officially licensed by Hong Kong statutory authorities, currently holding: Department of Health - Authorized Poison Seller (Licence No. 9/4A/2026); 2. Judicial Screening (Litigation & Winding-Up): screened against Hong Kong Judiciary cause books and winding-up registers under the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32), with zero public compulsory winding-up petitions (HCCW) or civil litigation dockets currently indexed.

The statutory registered office of TST Medicines Group Limited is registered at: [ROOM 7, G/F, LEE WAI COMMERCIAL BUILDING, 3 HART AVENUE, TSIM SHA TSUI, HONG KONG]. In accordance with Cap. 622 Section 658 and Cap. 622B Section 3, this Hong Kong address serves as the statutory venue for inspection of statutory registers, service of government and judicial process, and mandatory display of the corporation's full legal name.

Before entering into cross-border trade, credit settlement, or joint venture agreements with TST Medicines Group Limited (CRN: 3697824 / 8-digit BRN: 79542449), standard institutional due diligence under Hong Kong law comprises four core verifications: 1. Standing & Identifier Match: Cross-checking active status under Cap. 622 and its 8-digit BRN under Cap. 310; 2. Equity & Signatory Penetration: Inspecting the latest Annual Return (Form NAR1) and Form ND2A to verify paid-up share capital, shareholders, and authorized signatory directors; 3. Register of Charges Screening: Checking Form NM1 filings under Part 8 (Section 334) of Cap. 622 for pledged corporate assets or bank floating charges; and 4. Judicial Screening: Verifying the absence of High Court winding-up petitions (HCCW) or civil litigation writs.